A conditioned medium from a human liposarcoma-derived cell line induces p53-dependent apoptosis in several tumor cell lines

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 629-637

  Mancini, A ^a,d   Borrelli, A ^a   Masucci, M T ^a   Schiattarella, A ^a   Filice, S ^a   Rashan, J ^b   Maggino, T ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b AL AHLIYYA AMMAN UNIVERSITY   (Jordan)

^c UNIVERSITY OF PADOVA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adipocytes; Apoptosis; c myc; Cisplatin; Conditioned medium; Liposarcoma; p53

Indexed keywords

CISPLATIN; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; C3H MOUSE; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GLIOBLASTOMA; GUINEA PIG; HUMAN; LIPOSARCOMA; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; MUTAGEN TESTING; NECROSIS; PATHOLOGY; SALMONELLA TYPHIMURIUM; SKIN;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CISPLATIN; CULTURE MEDIA, CONDITIONED; FEMALE; GLIOBLASTOMA; GUINEA PIGS; HUMANS; LIPOSARCOMA; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MUTAGENICITY TESTS; NECROSIS; NEOPLASM METASTASIS; SALMONELLA TYPHIMURIUM; SKIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034185678     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.629     Document Type: Article

References (28)

1. Buick RN: The cellular basis of cancer chemotherapy in neoplastic agents. Remers WA (ed). John Wiley and Son Inc., Toronto, 1984.
2. Chabner BA: Bleomycin in Cancer Chemotherapy: Principles and Practice. 2nd edition. J.B. Lippincott Company, Philadelphia, pp341-355, 1990.
3. Wittes RE: Current enphasis in the clinical drug development program of the National Cancer Institute. In: Principles and Practice of Oncology. De Vita VT Jr, Hellman S and Rosenberg SA (eds). Updates I: 1-15, 1987.
4. Gurr E (ed): A pratical manual of medical and biological staining techniques. Leonard Hill, London, pp65-66, 1956.
5. Soule HD, Vazques J, Long A, Albert S and Brennan HJ: A human cell line from pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1413, 1973.
6. Huff KK and Lippman ME: Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells. Endocrinology 114: 1702-1710, 1984.
7. Busso N, Berlin D, Failly-Crepin C and Vassalli JD: Glucocorticoid modulation of plasminogen activator and one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res 47: 364-370, 1985.
8. Owens RB: Glandular epithelial cells from mice: a method for a selective cultivation. J Natl Cancer Inst 52: 1375-1378, 1974.
9. Mancini A, Borrelli A, Formisano S, Maffeo A, Perla G, de Martino L, Bevilacqua N, Botti G and Magino T: Establishment and growth regulation of a novel ovary cancer cell line from a poorly differentiated adenocarcinoma: a proposal for a new treatment. Vol. XX. Eur J Gynaecol Oncol 1: 45-52, 1999.
10. ink-4 deficiency in multiple tumor cell lines. Oncogene 10: 827-833, 1995.
11. Baish H, Gode W and Linden W: Analysis of PCP-data to deteminc the fraction of cells in various phases of the cell cycle. Radiat Environ Biophys, pp12-31, 1975.
12. Dyson NA: An introduction to nuclear physics with application in medicine and biology. Horwood, Chichester, 1981.
13. Sourogi P and Tagaki H: A role on the use of picric acid, paraformaldehyde-glutaraldehyde fixation for correlation light and electron microscopic immunocytochemistry. Neuroscience 7: 1979-1983, 1982.
14. Henkart PA: Mechanism of lynphocyte-mediated cytotoxicity. Ann Rev Immunol 3: 31-58, 1985.
15. Smith CA, Farrah T and Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994.
16. Nagata S and Goldstein P: The Fas death factor. Science 267: 1449-1456, 1995.
17. Murray AW: Creative blocks: cell cycle checkpoint and feedback controls. Nature 359: 599-604, 1992.
18. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
19. Mason DY: Immonocytochemical labeling of monoclonal antibodies by the APAAP immuno-alkaline phosphatase technique. Techniques Immunohistochem 35: 25-42, 1985.
20. Hsu S, Raine L and Fanger H: Use of avidin-biotin-pcroxidase complex (ABC) in immunoperoxidase tecniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
21. Squartini F: Tumors of the mammary gland. Pathology of tumors in laboratory animals. Vol. II. Tumors of the mouse. Turusov VS (ed), IARC, Lyon, pp43-67, 1979.
22. Walum E: Acute oral toxicity. Environ-Health Perpect 106 (Suppl 2): 497-503, 1998.
23. Baer RL: Cutaneous aspects of drug toxicity. Ann NY Acad Sci 123: 351-354, 1965.
24. Gettings SD, Lordo RA, Feder PI and Hintze KL: A comparison of low volume, Draize and in vitro eye irritation test data. Food Chem Toxicol 36: 209-231, 1998.
25. Juberg DR, David RM, Katz GV, Bernard LG, Gordon DR and Vlaovic MS: 2-Ethylxanoic acid: subcronic oral toxicity studies in the rat and mouse. Food Chem Toxicol 36: 429-436, 1998.
26. De Meo MP, Miribel V, Botta A, Laget M and Dumenil G: Applicability of the SOS Cromotest to detect urinary mutagenicity caused by smoking. Mutagenesis 3: 277-283, 1988.
27. Shravan K, Ali-Osman CF, Rayford SMA, Go R, Gokaslan ZL, Gacercas E, Venkaiah B, Sawaya R, Nicolson GL and Rao JS: Effect of cisplatin and BCNU on MMP levels in human glioblastoma cell lines in vitro. Clin Exp Metastasis 15: 361-367, 1997.
28. Hartshorn EA and Tatro DS: Principles of drug interactions in drug interaction facts. In: Facts and Comparisons. St. Louis, pp19-26, 1992.